Cell Therapeutics (CTIC -10%) slips after hitting an earlier 52-week high as the company...

|About: CTI BioPharma Corp. (CTIC)|By:, SA News Editor

Cell Therapeutics (CTIC -10%) slips after hitting an earlier 52-week high as the company announces the appointment of former managing director and head of West Coast Biotechnology for Oppenheimer, Matthew J. Plunkett, Ph.D., as it's executive vice president of Corporate Development. Dr. Plunkett has been tasked to lead the company's partnering strategy including development collaborations, licensing agreements, and strategic alliances.